Respicardia Receives $10,000,006 Series D Financing Round

  • Feed Type
  • Date
    9/5/2013
  • Company Name
    Respicardia
  • Mailing Address
    12400 Whitewater Dr Minnetonka, MN 55343
  • Company Description
    Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
  • Website
    http://www.respicardia.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,006
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.